Evidence suggests that the symptoms of bipolar disorder are recurrent and can worsen over repeated relapses. Even patients who follow treatment advice are still at a high relapse risk. Repeated relapses and rehospitalizations are main distresses, indicating a “downward spiral” of declined functioning and greater dependency on support and care by others.The goal is to effectively manage symptoms and prevent relapse. In this CME Outfitters patient case and expert consult Q & A session, Dr. Roger McIntyre goes in-depth with the case study answering questions while offering evidence, guidelines, and quality measures to manage residual symptoms and avoid relapse in patients with bipolar disorder.

Click here for activity details, credit information, and faculty bios!

Click Here to Collect Credit

A significant gap exists in awareness and knowledge amongst health care providers on the topic of biosimilars, creating perceived barriers within clinical practices. It’s imperative that clinicians are well-versed on the data surrounding interchangeability, safety, and efficacy of biosimilar agents so that they may confidently select the optimal treatment plan for their patients. In this CME Outfitters On Demand activity, real patient responses are at the center of the conversation, with expert faculty highlight the patients’ concerns while engaging in an evidence-based discussion on a variety of aspects of biosimilars.

Click here for activity details, credit information, and faculty bios!

Click Here to Collect Credit

Click here for activity details, credit information, and faculty bios!

Click Here to Collect Credit

Click here for activity details, credit information, and faculty bios!

Click Here to Collect Credit

Premiere Date: Thursday, June 8, 2017

This activity offers CE credit for:

All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™

Credit Expiration Date: Friday, June 8, 2018

Ulcerative colitis (UC) is an inflammatory bowel disease with a progressive course characterized by exacerbations and remissions. Traditionally, the goals of therapy for UC have entailed resolution of clinical symptoms such as rectal bleeding, bloody diarrhea, abdominal cramps, pain, and fatigue. However, treatment goals for UC have evolved to a treat-to-target strategy with targets such as mucosal/endoscopic healing, histologic healing, or deep remission (i.e., clinical, biochemical, and endoscopic remission) with the objective of preventing structural damage and disability. Conventional therapies have not been uniformly effective in achieving these aims, necessitating augmentation with steroids and carrying adverse risk often requiring discontinuation.

There has been an exponential growth in the pursuits of better targeted therapy to optimize IBD clinical outcomes. IBD therapies that explore new targets and inflammatory pathways are emerging to address the current treatment gaps observed with conventional and biologic therapies.

In this CME Outfitt

In this replay from a live CME Outfitters symposium, expert faculty guide learners through patient cases using an interactive infographic to explain the importance of initiating early targeted biologic therapy and provide evidence-based strategies to take action to achieve sustained remission and long-term clinical outcomes.

This activity offers CE credit for:

All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™

Credit Expiration Date: Friday, June 8, 2018

Ulcerative colitis (UC) is an inflammatory bowel disease with a progressive course characterized by exacerbations and remissions. Traditionally, the goals of therapy for UC have entailed resolution of clinical symptoms such as rectal bleeding, bloody diarrhea, abdominal cramps, pain, and fatigue. However, treatment goals for UC have evolved to a treat-to-target strategy with targets such as mucosal/endoscopic healing, histologic healing, or deep remission (i.e., clinical, biochemical, and endoscopic remission) with the objective of preventing structural damage and disability. Conventional therapies have not been uniformly effective in achieving these aims, necessitating augmentation with steroids and carrying adverse risk often requiring discontinuation.

There has been an e

Click here for activity details, credit information, and faculty bios!

Click Here to Collect Credit